Wu Shuo learned that YZi Labs posted on the X platform, once again criticizing CEA Industries (BNC) for restricting shareholders' right to take written action by introducing a poison pill plan and charter amendments, arguing that this move is to strengthen the board's power rather than protect shareholder interests. YZi Labs also denied BNC's claim that it never considered alternative tokens, pointing out that BNC CEO David Namdar explicitly stated at an industry conference in November 2025 that BNC had considered using other crypto assets, such as Solana. YZi Labs called on the board to avoid further manipulative actions and ensure a fair and transparent director nomination and election process at the 2025 shareholder meeting. YZi Labs has submitted a preliminary consent statement to the US Securities and Exchange Commission, seeking to expand BNC's board of directors and elect its nominated directors.
Wu Shuo learned that YZi Labs posted on the X platform, once again criticizing CEA Industries (BNC) for restricting shareholders' right to take written action by introducing a poison pill plan and charter amendments, arguing that this move is to strengthen the board's power rather than protect shareholder interests. YZi Labs also denied BNC's claim that it never considered alternative tokens, pointing out that BNC CEO David Namdar explicitly stated at an industry conference in November 2025 that BNC had considered using other crypto assets, such as Solana. YZi Labs called on the board to avoid further manipulative actions and ensure a fair and transparent director nomination and election process at the 2025 shareholder meeting. YZi Labs has submitted a preliminary consent statement to the US Securities and Exchange Commission, seeking to expand BNC's board of directors and elect its nominated directors.